Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
118.42
-4.54 (-3.69%)
At close: Sep 12, 2025, 4:00 PM EDT
118.99
+0.57 (0.48%)
After-hours: Sep 12, 2025, 6:27 PM EDT
Axsome Therapeutics Stock Forecast
Stock Price Forecast
The 17 analysts that cover Axsome Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $175.76, which forecasts a 48.42% increase in the stock price over the next year. The lowest target is $143 and the highest is $216.
Price Target: $175.76 (+48.42%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 6 |
| Buy | 8 | 8 | 9 | 10 | 10 | 11 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 16 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $163 | Buy | Initiates | $163 | +37.65% | Sep 3, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $173 → $176 | Strong Buy | Maintains | $173 → $176 | +48.62% | Aug 5, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $184 → $189 | Buy | Maintains | $184 → $189 | +59.60% | Aug 5, 2025 |
| Needham | Needham | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +26.67% | Aug 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $190 | Buy | Initiates | $190 | +60.45% | Jul 3, 2025 |
Financial Forecast
Revenue This Year
632.73M
from 385.69M
Increased by 64.05%
Revenue Next Year
989.98M
from 632.73M
Increased by 56.46%
EPS This Year
-3.75
from -5.99
EPS Next Year
0.79
from -3.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 682.5M | 1.1B | |||
| Avg | 632.7M | 990.0M | |||
| Low | 545.9M | 762.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 77.0% | 80.8% | |||
| Avg | 64.1% | 56.5% | |||
| Low | 41.5% | 20.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.94 | 4.20 | |||
| Avg | -3.75 | 0.79 | |||
| Low | -4.87 | -2.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.